Diagnosis and Management in Parkinson's Disease 2020
DOI: 10.1016/b978-0-12-815946-0.00005-3
|View full text |Cite
|
Sign up to set email alerts
|

Recent developments in the etiology, treatment, and potential therapeutic targets for Parkinson's disease: a focus on biochemistry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…PD is the second common neurodegenerative disorder that affects the serotonergic, adrenergic, and dopaminergic systems, causing a depletion in the neurotransmitters of the respective systems developing defective motor non-motor coordination [ 104 - 106 ]. Studies suggest the role of mutation of various variants, including α-synuclein, Leucine-rich repeat kinase 2 (LRRK 2), glucocerebrosidase gene (GBA), microtubule-associated protein τ (MAPT), MDR1, Parkin, and PINK1 [ 87 , 88 ].…”
Section: Neurodegenerative Disorders and Their Association With Mitoc...mentioning
confidence: 99%
“…PD is the second common neurodegenerative disorder that affects the serotonergic, adrenergic, and dopaminergic systems, causing a depletion in the neurotransmitters of the respective systems developing defective motor non-motor coordination [ 104 - 106 ]. Studies suggest the role of mutation of various variants, including α-synuclein, Leucine-rich repeat kinase 2 (LRRK 2), glucocerebrosidase gene (GBA), microtubule-associated protein τ (MAPT), MDR1, Parkin, and PINK1 [ 87 , 88 ].…”
Section: Neurodegenerative Disorders and Their Association With Mitoc...mentioning
confidence: 99%